Lv5
1170 积分 2022-11-21 加入
Distribution and therapeutic outcomes of intergenic sequence-ALK fusion and coexisting ALK fusions in lung adenocarcinoma patients
14小时前
待确认
A novel intergenic (between REG3A and CTNNA2-AS1)-ALK fusion responds to alectinib in lung adenocarcinoma
14小时前
已完结
Distribution and therapeutic outcomes of intergenic sequence-ALK fusion and coexisting ALK fusions in lung adenocarcinoma patients
14小时前
已完结
Evolving treatment for advanced Non-small cell lung cancer harbouring common EGFR activating mutations
1个月前
已完结
Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non-small-cell lung cancer and EGFR mutation
1个月前
已关闭
Building a BRIDGE for the integration of heterogeneous data from functional genomics into a platform for systems biology
1个月前
已完结
Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management
1个月前
已关闭
NRG1 Fusions: The New Kid on the Block
1个月前
已完结
Therapeutic targeting of mismatch repair-deficient cancers
1个月前
已完结
Measuring Progress in Precision Oncology
1个月前
已完结
皖公网安备34019202002308
